Stock Market News3 months NTLA Up as FDA Grants RMAT Status to Genome-Editing Therapy Zacks
The FDA bestows a Regenerative Medicine Advanced Therapy tag to Intellia’s nex-z for treating hereditary transthyretin (ATTR) amyloidosis with polyneuropathy.
XThe FDA bestows a Regenerative Medicine Advanced Therapy tag to Intellia’s nex-z for treating hereditary transthyretin (ATTR) amyloidosis with polyneuropathy.
X